These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 16960140)

  • 1. The calcineurin-NFAT pathway and bone: intriguing new findings.
    Stern PH
    Mol Interv; 2006 Aug; 6(4):193-6. PubMed ID: 16960140
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcineurin/NFAT signaling in osteoblasts regulates bone mass.
    Winslow MM; Pan M; Starbuck M; Gallo EM; Deng L; Karsenty G; Crabtree GR
    Dev Cell; 2006 Jun; 10(6):771-82. PubMed ID: 16740479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NFAT and Osterix cooperatively regulate bone formation.
    Koga T; Matsui Y; Asagiri M; Kodama T; de Crombrugghe B; Nakashima K; Takayanagi H
    Nat Med; 2005 Aug; 11(8):880-5. PubMed ID: 16041384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NFATc1: a novel anabolic therapeutic target for osteoporosis.
    Yeo H; McDonald JM; Zayzafoon M
    Ann N Y Acad Sci; 2006 Apr; 1068():564-7. PubMed ID: 16831953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
    Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
    Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of osteoclast differentiation and function by the CaMK-CREB pathway.
    Sato K; Suematsu A; Nakashima T; Takemoto-Kimura S; Aoki K; Morishita Y; Asahara H; Ohya K; Yamaguchi A; Takai T; Kodama T; Chatila TA; Bito H; Takayanagi H
    Nat Med; 2006 Dec; 12(12):1410-6. PubMed ID: 17128269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertrophy of the heart: calcineurin-NFAT pathway may be a new therapeutic target].
    Zhang YJ; Dong LF; Wang YL
    Yao Xue Xue Bao; 2006 Oct; 41(10):913-6. PubMed ID: 17184105
    [No Abstract]   [Full Text] [Related]  

  • 8. The molecular understanding of osteoclast differentiation.
    Asagiri M; Takayanagi H
    Bone; 2007 Feb; 40(2):251-64. PubMed ID: 17098490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of NFAT in osteoclast formation.
    Takayanagi H
    Ann N Y Acad Sci; 2007 Nov; 1116():227-37. PubMed ID: 18083930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of estrogen receptor alpha expression with decoy oligonucleotide targeted to NFATc1 binding sites in osteoblasts.
    Penolazzi L; Zennaro M; Lambertini E; Tavanti E; Torreggiani E; Gambari R; Piva R
    Mol Pharmacol; 2007 Jun; 71(6):1457-62. PubMed ID: 17389747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of the beta myosin heavy chain promoter by MEF-2D, MyoD, p300, and the calcineurin/NFATc1 pathway.
    Meissner JD; Umeda PK; Chang KC; Gros G; Scheibe RJ
    J Cell Physiol; 2007 Apr; 211(1):138-48. PubMed ID: 17111365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NFAT expression in human osteoclasts.
    Day CJ; Kim MS; Lopez CM; Nicholson GC; Morrison NA
    J Cell Biochem; 2005 May; 95(1):17-23. PubMed ID: 15759284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcineurin/NFAT pathway: a novel regulator of parturition.
    Tabata C; Ogita K; Sato K; Nakamura H; Qing Z; Negoro H; Kumasawa K; Temma-Asano K; Tsutsui T; Nishimori K; Kimura T
    Am J Reprod Immunol; 2009 Jul; 62(1):44-50. PubMed ID: 19527231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PIASxbeta is a key regulator of osterix transcriptional activity and matrix mineralization in osteoblasts.
    Ali MM; Yoshizawa T; Ishibashi O; Matsuda A; Ikegame M; Shimomura J; Mera H; Nakashima K; Kawashima H
    J Cell Sci; 2007 Aug; 120(Pt 15):2565-73. PubMed ID: 17623776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that calcineurin is required for the genesis of bone-resorbing osteoclasts.
    Sun L; Peng Y; Zaidi N; Zhu LL; Iqbal J; Yamoah K; Wang X; Liu P; Abe E; Moonga BS; Epstein S; Zaidi M
    Am J Physiol Renal Physiol; 2007 Jan; 292(1):F285-91. PubMed ID: 16968888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporin A promotes growth and invasiveness in vitro of human first-trimester trophoblast cells via MAPK3/MAPK1-mediated AP1 and Ca2+/calcineurin/NFAT signaling pathways.
    Du MR; Zhou WH; Dong L; Zhu XY; He YY; Yang JY; Li DJ
    Biol Reprod; 2008 Jun; 78(6):1102-10. PubMed ID: 18322274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aldehydic components of cinnamon bark extract suppresses RANKL-induced osteoclastogenesis through NFATc1 downregulation.
    Tsuji-Naito K
    Bioorg Med Chem; 2008 Oct; 16(20):9176-83. PubMed ID: 18823786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying genes that regulate bone remodeling as potential therapeutic targets.
    Krane SM
    J Exp Med; 2005 Mar; 201(6):841-3. PubMed ID: 15781576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes.
    Saygili E; Rana OR; Meyer C; Gemein C; Andrzejewski MG; Ludwig A; Weber C; Schotten U; Krüttgen A; Weis J; Schwinger RH; Mischke K; Rassaf T; Kelm M; Schauerte P
    Basic Res Cardiol; 2009 Jul; 104(4):435-48. PubMed ID: 19148693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BMP-2 regulation of PTHrP and osteoclastogenic factors during osteoblast differentiation of C2C12 cells.
    Susperregui AR; Viñals F; Ho PW; Gillespie MT; Martin TJ; Ventura F
    J Cell Physiol; 2008 Jul; 216(1):144-52. PubMed ID: 18247361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.